The State of Texas Top Legal Officer Sues Tylenol Producers Concerning Autism Assertions
Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, claiming the companies concealed alleged dangers that the medication presented to pediatric cognitive development.
This legal action comes four weeks after Donald Trump publicized an unproven link between taking Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in young ones.
The attorney general is taking legal action against Johnson & Johnson, which once produced the drug, the exclusive pain medication approved for expectant mothers, and the current manufacturer, which presently makes it.
In a statement, he said they "misled consumers by making money from suffering and marketing drugs without regard for the risks."
Kenvue says there is insufficient reliable data tying Tylenol to autism.
"These manufacturers misled for generations, intentionally threatening millions to line their pockets," the attorney general, from the Republican party, stated.
Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the health of US mothers and children."
On its online platform, Kenvue also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that indicates a verified association between using paracetamol and autism spectrum disorder."
Associations representing medical professionals and healthcare providers share this view.
The American College of Obstetricians and Gynecologists has stated paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and fever, which can pose major wellness concerns if ignored.
"In more than two decades of investigation on the utilization of acetaminophen in gestation, not a single reputable study has conclusively proven that the use of acetaminophen in any period of gestation leads to brain development issues in children," the organization stated.
This legal action cites latest statements from the previous government in claiming the medication is reportedly hazardous.
Last month, the former president generated worry from medical authorities when he instructed pregnant women to "fight like hell" not to take Tylenol when sick.
Federal regulators then issued a notice that doctors should think about restricting the consumption of Tylenol, while also mentioning that "a proven link" between the medication and autism in minors has not been established.
Health Secretary Robert F Kennedy Jr, who manages the FDA, had vowed in spring to initiate "comprehensive study program" that would identify the origin of autism in a limited time.
But specialists advised that identifying a unique factor of autism - believed by scientists to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.
Autism is a type of enduring cognitive variation and disability that affects how individuals encounter and relate to the surroundings, and is diagnosed using doctors' observations.
In his legal document, the attorney general - who supports Trump who is campaigning for the Senate - claims the manufacturer and J&J "willfully ignored and tried to quiet the evidence" around paracetamol and autism.
The case attempts to require the corporations "destroy any marketing or advertising" that states Tylenol is secure for expectant mothers.
The court case echoes the grievances of a group of parents of minors with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in recently.
A federal judge dismissed the lawsuit, stating research from the family's specialists was inconclusive.